secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENERON PHARMACEUTICALS, INC. (REGN)
CIK:        0000872589
Form:       8-K
Filed at:   2022-10-03T23:59:59+00:00
Accession:  0001104659-22-104901
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Regeneron elects Craig B. Thompson, M.D. as director; board expands to 13 members
--------------------------------------------------------------------------------

- Dr. Craig B. Thompson elected as director effective October 3, 2022; board expands from 12 to 13.
- Appointed to Technology Committee; term runs until 2023 Annual Shareholder Meeting.
- Compensation follows standard non-employee director practices described in April 21, 2022 proxy.
- No arrangement or understanding with any other person regarding his selection as director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872589/000110465922104901/0001104659-22-104901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872589/000110465922104901/tm2227120d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-104901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer